Trinity Biotech announced that its Premier Hb9210™ analyser received FDA clearance and the company plans to accelerate growth across its diagnostics franchise in Europe.
2 reports, 2 independent
Updated Sep 17
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trinity Biotech announced that its Premier Hb9210™ analyser received FDA clearance and the company plans to accelerate growth across its diagnostics franchise in Europe.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.
- FDA approval enables commercial opportunity involving CBRE Group.
- PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.
- A product was launched in the U.S. market following FDA involvement.